🔎 Trials Near Me

Dachaigh › Glomerulosclerosis fòcasach earrannach › North Carolina

Sgrùdaidhean clionaigeach Glomerulosclerosis fòcasach earrannach ann an North Carolina

Tha 9 sgrùdaidhean airson Glomerulosclerosis fòcasach earrannach a’ lorg phàirtichean aig làraichean ann an North Carolina.

Bailtean ann an North Carolina

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

  • Investigator Site #16, New Bern
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07268638

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

  • Duke University Medical Center, Durham
  • Carolina Kidney Associates, Greensboro
  • Cardinal Clinical Research, LLC - Shelby, Shelby
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07220083

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  • UNC Kidney Center- Site Number : 8400021, Chapel Hill
A’ fastadhÌre 2
Aoisean 16 gu 75 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06500702

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

  • University of North Carolina, Chapel Hill
A’ fastadh
Suas gu aois 75 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT04065438

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • University of North Carolina, Chapel Hill
A’ fastadh
Suas gu aois 21 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT02235857

Nephrotic Syndrome Study Network

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Atrium Health Levine Children's Hospital, Charlotte
A’ fastadhSgrùdadh amharc
Suas gu aois 80 · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT01209000

NEPTUNE Match Study

  • University of North Carolina Chapel Hill, Chapel Hill
A’ fastadh
Aoisean 1 gu 80 · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT04571658

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Duke Molecular Physiology Institute, Durham
A’ fastadhÌre 2
Aoisean 1 gu 17 · Gach gnè · Air ùrachadh 12 Cèit 2026 · NCT05003986

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

  • University of North Carolina, Chapel Hill
  • Atrium Health, Charlotte
A’ fastadhÌre 3
Aoisean 12 gu 80 · Gach gnè · Air ùrachadh 3 Gearr 2026 · NCT05183646

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.